Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid Leukemia

Georgia Koutsoumpli, Dyantha I. van der Lee, Nina C. Groenland, M. Willy Honders, Rob C.M. de Jong, Renate S. Hagedoorn, Hendrik Veelken, Peter A. van Veelen, Dominik Lock, Mirjam H.M. Heemskerk, J.H.Frederik Falkenburg, Ian Johnston, Marieke Griffioen

Blood (2022) 140 (Supplement 1): 10243–10244.

https://doi.org/10.1182/blood-2022-158195

Published: 2022

Journal Articles

High-Dimensional Mass Cytometric Analysis of the Bone Marrow Compartment Identifies a Disease-Specific Immune Cell Network in Aplastic Anemia

Emma S. Pool, Yvonne Kooy-Winkelaar, Vincent van Unen, J.H.Frederik Falkenburg, Frits Koning, Mirjam H.M. Heemskerk, Jennifer M.L. Tjon

Blood (2022) 140 (Supplement 1): 477–478.

https://doi.org/10.1182/blood-2022-162187

Published: 2022

Journal Articles

Immunotherapy By Targeting CD45 in Mismatched HLA-DP to Treat Patients after Allogeneic Stem Cell Transplantation

Nadine E. Struckman, Sebastian Klobuch, Michel G.D. Kester, Wendy de Klerk, Arnoud H. de Ru, Mirjam H.M. Heemskerk, Peter A. van Veelen, Peter van Balen, J.H.Frederik Falkenburg, Marieke Griffioen

Blood (2022) 140 (Supplement 1): 4545–4546.

https://doi.org/10.1182/blood-2022-166282

Published: 2022

Journal Articles

HLA-DM Mediates Permissiveness of HLA-DPB1 T Cell Epitope Mismatches in Unrelated HCT

Maximilian Metzing, Pietro Crivello, Thuja Meurer, Michel G.D. Kester, ing., Dominik Megger, Weiqiang Chen, Peter Van Balen, MD, Marieke Griffioen, PhD, Peter A. Horn, Barbara Sitek, J.H.Frederik Falkenburg, MD PhD, Esteban Arrieta-Bolaños, Katharina Fleischhauer, MD

Blood (2019) 134 (Supplement_1): 3211.

https://doi.org/10.1182/blood-2019-129921

Published: 2019

Journal Articles

Relative Contribution of Naïve and Memory T Cells to Alloreactivity in Hematopoietic Cell Transplantation

Esteban Arrieta-Bolaños, Maryam Mohamaddokht, Thuja Meurer, Pietro Crivello, Amin T. Turki, MD PhD, Peter A. Horn, Dietrich W. Beelen, J.H.Frederik Falkenburg, MD PhD, Katharina Fleischhauer, MD

Blood (2019) 134 (Supplement_1): 1923.

https://doi.org/10.1182/blood-2019-130273

Published: 2019

Journal Articles

Durable Remission of Renal Cell Carcinoma After Donor Lymphocyte Infusion Is Unavoidably Linked with Graft Versus Host Disease As Illustrated by the Detection of Allo Reactive T Cells Recognizing a Novel Minor Histocompatibility Antigen Encoded by the FUCA2 Gene

Cornelis A.M. van Bergen, Elizabeth M.E. Verdegaal, PhD, Conny Hoogstraten, A.Q.M. Jeanne van Steijn, Linda de Quartel, Joan H. de Jong, Maaike Meyering, Marieke Griffioen, PhD, J.H.Frederik Falkenburg, MD, PhD, Susanne Osanto, MD, PhD

Blood (2012) 120 (21): 4467.

https://doi.org/10.1182/blood.V120.21.4467.4467

Published: 2012

Journal Articles

Low Incidence of Post-Transplant EBV-Related Disease After Alemtuzumab-Mediated T Cell Depletion Is Explained by the Differential Susceptibility to Alemtuzumab of B Cells and Protective CD8 and CD4 T Cells

Constantijn J.M. Halkes, MD, PhD, Inge Jedema, PhD, Judith Olde Wolbers, Esther M van Egmond, Peter A. Von Dem Borne, MD, PhD, Erik W.A.F. Marijt, MD, PhD, J.H.Frederik Falkenburg, MD, PhD

Blood (2010) 116 (21): 2330.

https://doi.org/10.1182/blood.V116.21.2330.2330

Published: 2010

Journal Articles

Identification of Multiple HLA Class II Epitopes of Aspergillus Fumigatus by Generation of CD4+ T Cell Clones Recognizing the A. Fumigatus proteins Crf1 and Catalase1

Hetty Jolink, MD, Els van Oorschot, Ed J Kuijper, MD, PhD, Jan Willem Drijfhout, PhD, Jaap T van Dissel, MD, PhD, J.H.Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2010) 116 (21): 2332.

https://doi.org/10.1182/blood.V116.21.2332.2332

Published: 2010

Journal Articles

Physiological TCR Modulation after Antigen Specific Triggering of Introduced TCRs under Control of a Retroviral Promotor.

Marleen M. van Loenen, Renate S. Hagedoorn, Esther H.M. van Egmond, Roel Willemze, MD, PhD, J.H.Frederik Falkenburg, MD, PhD, Mirjam H.M. Heemskerk, PhD

Blood (2005) 106 (11): 5537.

https://doi.org/10.1182/blood.V106.11.5537.5537

Published: 2005

NARROW

Immunotherapy Targeting Mutant Nucleophosmin-1 on Acute Myeloid Leukemia

High-Dimensional Mass Cytometric Analysis of the Bone Marrow Compartment Identifies a Disease-Specific Immune Cell Network in Aplastic Anemia

Immunotherapy By Targeting CD45 in Mismatched HLA-DP to Treat Patients after Allogeneic Stem Cell Transplantation

HLA-DM Mediates Permissiveness of HLA-DPB1 T Cell Epitope Mismatches in Unrelated HCT

Relative Contribution of Naïve and Memory T Cells to Alloreactivity in Hematopoietic Cell Transplantation

Durable Remission of Renal Cell Carcinoma After Donor Lymphocyte Infusion Is Unavoidably Linked with Graft Versus Host Disease As Illustrated by the Detection of Allo Reactive T Cells Recognizing a Novel Minor Histocompatibility Antigen Encoded by the FUCA2 Gene

Low Incidence of Post-Transplant EBV-Related Disease After Alemtuzumab-Mediated T Cell Depletion Is Explained by the Differential Susceptibility to Alemtuzumab of B Cells and Protective CD8 and CD4 T Cells

Identification of Multiple HLA Class II Epitopes of Aspergillus Fumigatus by Generation of CD4+ T Cell Clones Recognizing the A. Fumigatus proteins Crf1 and Catalase1

Physiological TCR Modulation after Antigen Specific Triggering of Introduced TCRs under Control of a Retroviral Promotor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only